Results 31 to 40 of about 9,407 (166)

Protection Effect of Self-Nanoemulsifying Drug Delivery System (SNEDDS) Piroxicam as Ulcerogenic Agent towards Malondialdehid Level and Protein Expression of Caspase-3, COX-1, COX-2 at Rat Gastric

Journal of Food and Pharmaceutical Sciences, 2020
The aim of this study was to determine the protection effect of SNEDDS piroxicam ulcerogenic agent against malondialdehyde (MDA) level and protein expression of caspase-3, COX-1, COX-2. The research was conducted using the test animals as much as 30 male
Iis Wahyuningsih, Kurnia Ambarwati, Erninda Ayu Hapsari, Afifah Fauziyyah, Azis Ikhsanudin, Deasy Vanda Pertiwi, Wahyu Widyaningsih   +6 more
doaj   +1 more source

Fabrication of Sensitive Voltammetric Sensors and Microsensors for Piroxicam by Modifying Nafion and MWCNTs Composite Film on the Electrode Surface

Electrochemistry
Piroxicam is a common painkiller and anti-inflammatory drug. Precise monitoring of piroxicam levels can mitigate side effects, but current methods are often slow and complicated. An easily fabricated and highly sensitive voltammetric sensor for piroxicam
Jin LI, Siyuan HAN, Yue CUI, Tong XING, Tingting ZHENG, Jing YANG, Yu FU, Jie LIAN, Fangyuan ZHAO, Weining ZHAO   +9 more
doaj   +1 more source

Design and formulation of piroxicam tablets [PDF]

المجلة العراقية للصيدلة, 2008
Piroxicam is a potent nonsteroidal anti-inflammatory drug (NSAID) with a long half-life that permits once daily dose. It exerts a better toleration than other NSAID's with a relatively low incidence of adverse effects.
Shaimaa Dhia M.S. Al-Shakarchi
doaj   +1 more source

Formulation and optimization of quinoa starch nanoparticles: Quality by design approach for solubility enhancement of piroxicam

Saudi Pharmaceutical Journal, 2020
In the present study piroxicam loaded starch nanoparticles were prepared to enhance the solubility of piroxicam by nanoprecipitation technique. The preparation of nanoparticles was carried out as per central composite experimental design protocol, having
Meenakshi Bhatia, Sulekha Rohilla
doaj   +1 more source

PREPARATION AND EVALUATION OF PIROXICAM - PLURONIC SOLID DISPERSIONS [PDF]

Bulletin of Pharmaceutical Sciences. Assiut University, 2003
With an objective of enhancing the dissolution rate of piroxicam (PXM), solid dispersions(SDs) of piroxicam were prepared using different grades of pluronic F-68 (Pl. F-68), pluronicF-98 (Pl. F-98), and pluronic F-127 (Pl.
M. El-Badry, M. Fathy
doaj   +1 more source

Thrombocytosis and tumour distribution predict outcome in dogs with hepatocellular carcinoma: A multi‐institutional retrospective analysis

Veterinary Record, EarlyView.
Abstract Background Hepatocellular carcinoma (HCC) is the most common canine hepatobiliary tumour. This study aimed to determine which criteria influenced outcome of HCC in a modern population of dogs across eight institutions. Methods The medical records of 106 dogs with HCC were retrospectively reviewed.
Emily A. Janik, MacKenzie A. Pellin, Dawn M. Clarke   +2 more
wiley   +1 more source

Improved anti-nociceptive, anti-pyretic and anti-inflammatory effects of orally administered liposome-encapsulated piroxicam [PDF]

Piroxicam, a nonsteroidal anti-inflammatory drug, has been shown with low oral bioavailability and delayed onset of its therapeutic effects. In this work, a promising nano/ liposomal drug delivery system was exploited to improve the in vivo therapeutic ...
Yong, Y.K., Hakim, M.N., Chiong, H.S., Sulaiman, M.R., Yuen, K.H., Mohd Hijaz, M.S.   +5 more
core   +1 more source

Formulation and Characterization of Piroxicam as Self-Nano Emulsifying Drug Delivery System

Iraqi Journal of Pharmaceutical Sciences, 2020
Piroxicam (PIR) is a nonsteroidal anti-inflammatory drug of oxicam category, used in gout, arthritis, as well as other inflammatory conditions (topically and orally).
Fahad F. Salim, Nawal A. Rajab
doaj   +1 more source

Comparison of pharmacogenomic guidance in Australian prescribing resources and international pharmacogenomic guidelines

Internal Medicine Journal, EarlyView.
Abstract Background Pharmacogenomic‐guided medication management optimises drug therapy to enhance patient outcomes. Despite clinical utility, implementation in Australia remains limited, partly due to the lack of clear and consistent guidance. Aim This study evaluated the presence and consistency of pharmacogenomic testing indication categories and ...
Ruby Soueid, Jackson L. A. Thomas, Luke B. Hesson, Stephen Hughes, Sophie L. Stocker   +4 more
wiley   +1 more source

Albumin microspheres for ocular delivery of piroxicam

, 2000
This investigation deals with the preparation, in-vitro characterization and preliminary in-vivo evaluation of albumin microspheres containing piroxicam.
Saettone MF, Glunchedi P, Conte U, CHETONI, PATRIZIA   +3 more
core   +1 more source